Moods Disorders Completed Phase 1 Trials for L-Arginine (DB00125)

Also known as: Mood Disorders / Mood Disorder

IndicationStatusPhase
DBCOND0058256 (Moods Disorders)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00990067Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)Basic Science